Image

ERAS Compliance and Nutritional Outcomes After Lung Cancer Surgery

ERAS Compliance and Nutritional Outcomes After Lung Cancer Surgery

Recruiting
18-85 years
All
Phase N/A

Powered by AI

Overview

This prospective observational study will evaluate the association between ERAS protocol compliance and postoperative nutritional outcomes in 120 patients undergoing lung cancer surgery. ERAS compliance will be recorded, and patients will be classified as having high, moderate, or low compliance. NRS-2002 and PNI will be assessed before surgery and at postoperative 48 hours. Hospital stay and postoperative complications will also be evaluated.

Description

This single-center observational cohort study will include 120 patients aged 18-85 years undergoing elective lung cancer surgery. No intervention will be assigned. ERAS compliance will be categorized as high (≥80%), moderate (60-79%), or low (\<60%). Changes in NRS-2002 and PNI, hospital stay, and postoperative complications will be evaluated using routine clinical data.

Eligibility

Inclusion Criteria:

  • Age between 18 and 85 years
  • Scheduled for elective lung cancer surgery under general anesthesia
  • ASA physical status I-III
  • Able to provide written informed consent

Exclusion Criteria:

  • Emergency surgery
  • Preoperative total parenteral nutrition
  • Advanced organ failure
  • Uncontrolled metabolic disease
  • Pregnancy or breastfeeding
  • Inability to provide informed consent

Study details
    Lung Cancer

NCT07785791

Bursa City Hospital

29 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.